Articles by Margery L.S. Gass

Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey

Gass, Margery L.S.; Stuenkel, Cynthia A.; Utian, Wulf H.; More

Menopause. 22(12):1276-1285, December 2015.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause...

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American...

Portman, David J.; Gass, Margery L.S.; on behalf of the Vulvovaginal Atrophy Terminology Consensus Conference Panel

Menopause. 21(10):1063-1068, October 2014.

Why the product labeling for low-dose vaginal estrogen should be changed

Manson, JoAnn E.; Goldstein, Steven R.; Kagan, Risa; More

Menopause. 21(9):911-916, September 2014.

Letters to the Editor

Gass, Margery L.S.; Manson, JoAnn; Stuenkel, Cynthia; More

Menopause. 19(7):836-837, July 2012.

Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative

Gass, Margery L.S.; Cochrane, Barbara B.; Larson, Joseph C.; More

Menopause. 18(11):1160-1171, November 2011.

  • Editorial

The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety

Stovall, Dale W.; Utian, Wulf H.; Gass, Margery L.S.; More

Menopause. 14(3):510-517, May-June 2007.